Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Other Operating Liabilities
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Other Operating Liabilities of $10.21 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2017-05-09
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating liabilities for the quarter ending 2016-09-30 was $1.29K.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating liabilities for the quarter ending 2016-06-30 was $1.01K.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other operating liabilities for the quarter ending 2016-03-31 was $7.91K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month |
|---|---|---|---|
| 2016-09-30 | $1.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $2.30K derived: sum of 2 quarters · filed 2016-11-10 | $10.21K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $8.91K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $7.91K 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |